Teva Pharmaceutical Industries Ltd. today announced that it has entered into a definitive agreement under which Teva will acquire NuPathe Inc. for $3.65 per share in cash, or approximately $144 million.
http://ift.tt/KyveuF
http://ift.tt/KyveuF
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment